Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression.

Khedr ME, Lee Y, Mirza MA, Jimenez H, Greer D

Open source

DOI
10.1002/brb3.71792
Published
2026 Sep
Container
Brain and behavior
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/brb3.71792,
  title = {Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression.},
  author = {Khedr ME and Lee Y and Mirza MA and Jimenez H and Greer D},
  year = {2026},
  journal = {Brain and behavior},
  doi = {10.1002/brb3.71792},
  url = {https://doi.org/10.1002/brb3.71792}
}

RIS

TY  - JOUR
TI  - Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression.
AU  - Khedr ME
AU  - Lee Y
AU  - Mirza MA
AU  - Jimenez H
AU  - Greer D
PY  - 2026
JO  - Brain and behavior
DO  - 10.1002/brb3.71792
UR  - https://doi.org/10.1002/brb3.71792
ER  - 

APA

ME, K., Y, L., MA, M., H, J., & D, G. (2026). Comparing the Impact of Tetrahydrocannabinol on 30-Day Readmission Rates and Hospital Length of Stay in Patients With Depression.. Brain and behavior. https://doi.org/10.1002/brb3.71792

Source records